Systems biology bioinformatics approaches will be needed to determine whether or not multiple aberrant signals in patients with metastatic tumors converge on pathways such as PI3K/AKT/mTOR pathway, and are hence actionable. The gene discussed is MTOR; the disease is metastatic neoplasm.